Medical research

Mouth rinse for HPV DNA may be biomarker in head, neck cancer

(HealthDay)—Human papillomavirus (HPV) DNA detected from a mouth rinse may be an effective marker for prognosis during treatment of HPV-positive head and neck cancer, according to a study recently published in JAMA Oncology.

Oncology & Cancer

CDC: Recent decline seen in high-grade cervical lesions

(HealthDay)—The number of cervical precancers (CIN2+ cases) in the United States declined from 2008 to 2016, likely in part because of prevention with the human papillomavirus (HPV) vaccine, according to research published ...

Oncology & Cancer

Why the HPV vaccine is more important than ever

(HealthDay)—HPV, the human papillomavirus, is the most common sexually transmitted infection in the United States, with 14 million new cases each year.

Oncology & Cancer

Cervical microbiome may promote high-grade precancerous lesions

Infections with a Human Papillomavirus (HPV) cause 99 percent of cervical cancer cases, and the disease's first sign is often the appearance of precancerous lesions on a woman's cervix. But bacteria may play an important ...

Oncology & Cancer

Study 'strongly supports' extending cervical screening intervals

Screening for high risk human papillomavirus (HR-HPV) infection works well in practice and is more sensitive than cytology (smear) testing—offering greater protection against cervical cancer, confirm researchers in The ...

page 16 from 40